Tag: Nanomaterials in Personalized Medicine Market Forecast

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Nanomaterials In Personalized Medicine Market Value Growth And Long-Term Outlook

The market size for nanomaterials in personalized medicine has seen rapid expansion in recent years. It is projected to increase from $392.97 billion in 2025 to $438.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The historical growth of this market can be attributed to advancements in genomics and molecular biology, the growing adoption of targeted therapies, the expansion of translational medical research, the availability of advanced nanofabrication techniques, and the increase in academic-industry collaborations.

The market size for nanomaterials in personalized medicine is anticipated to experience substantial growth in the coming years. It is predicted to expand to $674.28 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is driven by factors such as the increasing demand for personalized healthcare solutions, rising investment in precision medicine programs, the broadening application of nanomaterials in diagnostics and imaging, a heightened focus on minimizing therapy side effects, and ongoing innovation in nano-enabled medical technologies. Key trends during this period include the increased use of targeted nanomaterials for individualized therapies, the growing integration of molecular diagnostics with nanotechnology, a rising adoption of nanomaterials in precision drug delivery, the expansion of nanotechnology into regenerative medicine, and an enhanced emphasis on patient-specific treatment outcomes.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=93153955&type=smp&name=Nanomaterials%20In%20Personalized%20Medicine%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Nanomaterials In Personalized Medicine Market Growth Factors: What’s Supporting Expansion?

The rising demand for personalized medicine is anticipated to drive the expansion of the nanomaterials in personalized medicine market going forward. Personalized medicine is a medical approach that entails customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to maximize positive outcomes and enhance patient care. The demand for personalized medicine is growing owing to progress in genomic technologies, which facilitate accurate identification of genetic variations and tailored treatments for individuals. Nanomaterials in personalized medicine contribute to personalized medicine by supporting targeted and patient-specific therapies, leading to improved treatment effectiveness and safety. They permit the exact delivery of drugs, genes, or RNA, thereby lessening side effects and optimizing therapeutic results. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. Consequently, the growing demand for personalized medicine is propelling the growth of the nanomaterials in personalized medicine market.

Nanomaterials In Personalized Medicine Market Breakdown By Product Type And Application

The nanomaterials in personalized medicine market covered in this report is segmented –

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

Nanomaterials In Personalized Medicine Market Industry Trends: What’s Reshaping Demand?

Leading companies in the nanomaterials in personalized medicine market are prioritizing strategic collaborations to expedite clinical translation, broaden therapeutic indications, and shorten time-to-market, all while conforming to evolving regulatory standards. These strategic collaborations represent partnerships where companies or institutions combine their expertise and resources to accelerate innovation and expand opportunities within personalized medicine. For example, in May 2025, Acuitas Therapeutics Inc., a Canada-based biotechnology company, joined forces with Integrated DNA Technologies Inc., a US-based genomics solutions provider. They launched a personalized CRISPR gene-editing therapy delivery system using their lipid nanoparticles platform, which was used to treat a single baby with a rare genetic disease. This treatment featured precisely targeted CRISPR payloads, bespoke dose tuning, and rapid custom formulation. This advancement accelerates the development of highly individualized, one-off treatments. While it enhances therapeutic precision and improves patient outcomes, it also introduces challenges related to scalable manufacture, stringent regulatory tailoring, and ultra-low-volume production.

Nanomaterials In Personalized Medicine Market Company Landscape And Competitive Strategy

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

View The Full Nanomaterials In Personalized Medicine Market Report:

https://thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Nanomaterials In Personalized Medicine Market Regional Split: Which Areas Are Fueling Growth?

North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Nanomaterials In Personalized Medicine Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for nanomaterials in personalized medicine has experienced swift expansion in recent times. Projected figures indicate a rise from $392.97 billion in 2025 to $438.79 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.7%. This historic growth is driven by progress in genomics and molecular biology, a growing embrace of targeted treatments, broader translational medical research, access to sophisticated nanofabrication methods, and strengthened partnerships between academia and industry.

The market for nanomaterials in personalized medicine is projected to experience substantial expansion over the coming years. By 2030, its value is anticipated to reach $674.28 billion, reflecting a compound annual growth rate (CAGR) of 11.3%. This forecasted growth is driven by several factors, including a heightened demand for tailored healthcare approaches, increased funding for precision medicine initiatives, broader applications of nanomaterials in diagnostics and imaging, a stronger emphasis on reducing adverse effects from treatments, and ongoing advancements in nano-enabled medical technologies. Key trends shaping this period involve the expanded use of targeted nanomaterials for customized therapies, the deeper integration of molecular diagnostics with nanotechnology, the growing application of nanomaterials in precise drug delivery systems, the widening role of nanotechnology in regenerative medicine, and a more pronounced focus on achieving patient-specific therapeutic outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Nanomaterials In Personalized Medicine Market Growth Momentum: Which Factors Are Influencing Demand?

The growing interest in personalized medicine is expected to fuel expansion in the nanomaterials in personalized medicine market. Personalized medicine refers to a medical strategy that customizes treatments for each patient, taking into account their genetic, environmental, and lifestyle factors to enhance outcomes and improve care quality. This demand is rising due to progress in genomic technologies, which allow for the accurate detection of genetic differences and the development of tailored treatments for individuals. Within this field, nanomaterials contribute by supporting targeted, patient-specific therapies that boost treatment effectiveness and safety. They facilitate the precise administration of drugs, genes, or RNA, minimizing adverse effects and maximizing therapeutic benefits. As an example, in February 2024, the Personalized Medicine Coalition (PMC), a U.S.-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable jump from 12 approvals in 2022. Consequently, the rising demand for personalized medicine is propelling the nanomaterials in personalized medicine market forward.

Nanomaterials In Personalized Medicine Market Segment Landscape And Growth Potential

The nanomaterials in personalized medicine market covered in this report is segmented –

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

Nanomaterials In Personalized Medicine Market Trends Reshaping Industry Growth

Major firms in the nanomaterials used for personalized medicine are increasingly pursuing strategic collaborations to speed up clinical application, broaden the range of treatable conditions, and reduce the time required to bring products to market, all while complying with evolving regulatory demands. Such partnerships involve organizations pooling their specialized knowledge and assets to drive innovation and create new opportunities within personalized healthcare. For example, in May 2025, Acuitas Therapeutics Inc., a Canadian biotechnology firm, teamed up with Integrated DNA Technologies Inc., a US-based provider of genomics tools, to unveil a tailored CRISPR gene-editing therapy delivery system built on their lipid nanoparticle platform. This system was applied to treat a single infant suffering from a rare genetic disorder, incorporating precisely targeted CRISPR components, customized dosing adjustments, and swift bespoke formulation. This breakthrough enables rapid, highly individualized therapeutic approaches. It enhances treatment accuracy and patient outcomes, yet presents hurdles in scalable production, meticulous regulatory adaptation, and small-scale manufacturing.

Nanomaterials In Personalized Medicine Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Access The Complete Nanomaterials In Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Nanomaterials In Personalized Medicine Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Nanomaterials In Personalized Medicine Market From 2026 To 2030?

The nanomaterials in personalized medicine market has seen significant expansion in recent years. The market is projected to increase from $392.97 billion in 2025 to $438.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historical growth can be attributed to advancements in genomics and molecular biology, increasing adoption of targeted therapies, expansion of translational medical research, availability of advanced nanofabrication techniques, and growth of academic-industry collaborations.

The market size for nanomaterials in personalized medicine is projected to experience substantial growth in the upcoming years. It is set to expand to $674.28 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.3%. This anticipated expansion during the forecast period is driven by factors such as an escalating demand for personalized healthcare options, increased investment in precision medicine programs, wider application of nanomaterials in diagnostics and imaging, a heightened emphasis on reducing therapy side effects, and continuous innovation in nano-enabled medical technologies. Significant trends expected in the forecast period include the increasing deployment of targeted nanomaterials for individualized treatments, the growing integration of molecular diagnostics with nanotechnology, a rise in the adoption of nanomaterials for precision drug delivery, the expansion of nanotechnology into regenerative medicine, and an enhanced focus on patient-specific treatment outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

What Are The Main Drivers Accelerating The Growth Of The Nanomaterials In Personalized Medicine Market?

The growing demand for personalized medicine is projected to drive the expansion of the nanomaterials in personalized medicine market moving forward. This medical methodology involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize results and enhance care. The need for personalized medicine is on the rise, driven by advancements in genomic technologies that enable precise identification of genetic variations and the development of tailored treatments for individuals. Nanomaterials in personalized medicine further enhance this approach by facilitating targeted and patient-specific therapies, thereby improving treatment effectiveness and safety. They allow for the precise delivery of drugs, genes, or RNA, which helps in reducing side effects and optimizing therapeutic outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Thus, the increasing demand for personalized medicine is fundamentally propelling the growth of the nanomaterials in personalized medicine market.

How Are Different Segment Groups Identified Within The Nanomaterials In Personalized Medicine Market?

The nanomaterials in personalized medicine market covered in this report is segmented –

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

Which Trends Are Affecting The Nanomaterials In Personalized Medicine Market Framework?

Leading entities within the nanomaterials in personalized medicine market are increasingly focusing on forming strategic partnerships to expedite clinical development, broaden therapeutic applications, and reduce time-to-market, all while adhering to evolving regulatory frameworks. These strategic collaborations represent alliances where organizations merge their specialized knowledge and assets to hasten innovation and broaden prospects within personalized medicine. As an illustration, in May 2025, Acuitas Therapeutics Inc., a Canadian biotechnology firm, partnered with Integrated DNA Technologies Inc., a genomics solutions provider from the US, to introduce a personalized CRISPR gene-editing therapy administered via their lipid nanoparticles platform. This treatment was successfully applied to a single infant suffering from a rare genetic condition, utilizing precisely aimed CRISPR elements, customized dosage adjustment, and swift bespoke preparation. Such advancements accelerate the delivery of unique, highly tailored treatments. While enhancing therapeutic accuracy and improving patient results, this approach also introduces difficulties related to scalable manufacturing, strict regulatory customization, and very low-volume production.

Which Industry Players Are Present In The Nanomaterials In Personalized Medicine Market?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Access The Complete Nanomaterials In Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

Which Region Leads The Nanomaterials In Personalized Medicine Market By Size?

North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nanomaterials In Personalized Medicine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company

Nanomaterials In Cosmetic And Personal Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-cosmetic-and-personal-care-global-market-report

Nanomedicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Healthcare Nanotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Nanomaterials In Personalized Medicine Market Projected To Reach By 2030?

The market size for nanomaterials in personalized medicine has seen rapid expansion over recent years. This sector is anticipated to increase from $392.97 billion in 2025 to $438.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be attributed to several factors including advancements in genomics and molecular biology, the rising adoption of targeted therapies, the expansion of translational medical research, the availability of advanced nanofabrication techniques, and the growth of academic-industry collaborations.

The market size for nanomaterials in personalized medicine is set to undergo significant expansion in the coming years. It is projected to climb to $674.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. This anticipated growth throughout the forecast period stems from factors such as increasing demand for customized healthcare solutions, greater investment in precision medicine programs, the wider application of nanomaterials in diagnostics and imaging, an intensified focus on minimizing therapy side effects, and continuous innovation in nano-enabled medical technologies. Prominent trends for the forecast period include the expanding use of targeted nanomaterials for individualized therapies, the rising integration of molecular diagnostics with nanotechnology, a growing adoption of nanomaterials in precise drug delivery, the broadening scope of nanotechnology in regenerative medicine, and an increased emphasis on patient-specific treatment outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

What Key Factors Are Affecting The Nanomaterials In Personalized Medicine Market Demand?

The burgeoning need for personalized medicine is anticipated to fuel the expansion of the nanomaterials in personalized medicine market in the future. Personalized medicine represents a medical strategy focused on customizing treatments for individual patients, considering their genetic makeup, environmental influences, and lifestyle elements to enhance results and refine care. The surge in personalized medicine’s popularity stems from progress in genomic technologies, facilitating the accurate detection of genetic differences and the creation of bespoke treatments for individuals. Nanomaterials in personalized medicine elevate personalized medicine by facilitating targeted, patient-specific therapeutic interventions, thereby boosting treatment effectiveness and safety. These materials permit the exact administration of drugs, genes, or RNA, consequently diminishing adverse effects and optimizing therapeutic results. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the escalating need for personalized medicine is propelling the expansion of the nanomaterials in personalized medicine market.

What Are The Main Segments Within The Nanomaterials In Personalized Medicine Market Segment Structure?

The nanomaterials in personalized medicine market covered in this report is segmented –

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

What Trends Are Shaping The Future Of The Nanomaterials In Personalized Medicine Market?

Companies operating within the nanomaterials in personalized medicine market are increasingly focusing on forming strategic collaborations to expedite clinical progress, broaden therapeutic applications, and reduce time to market, all while complying with evolving regulatory standards. These strategic partnerships involve organizations or institutions combining their expertise and resources to accelerate innovation and expand opportunities in personalized medicine. For instance, in May 2025, Acuitas Therapeutics Inc., a Canada-based biotechnology company, collaborated with Integrated DNA Technologies Inc., a US-based genomics solutions provider. They jointly launched a personalized CRISPR gene-editing therapy delivery, leveraging their lipid nanoparticles platform, which was used to treat a single baby with a rare genetic disease. This treatment featured precisely targeted CRISPR payloads, bespoke dose tuning, and rapid custom formulation. This innovation accelerates one-off, highly individualized treatments, enhancing therapeutic precision and patient outcomes, though it also presents challenges in terms of scalable manufacturing, stringent regulatory customization, and ultra-low-volume production.

Who Are The Companies Participating In The Nanomaterials In Personalized Medicine Market?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Get The Full Nanomaterials In Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

Which Geographic Region Dominates The Nanomaterials In Personalized Medicine Market?

North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Nanomaterials In Personalized Medicine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company

Nanomaterials In Cosmetic And Personal Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-cosmetic-and-personal-care-global-market-report

Nanomedicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Healthcare Nanotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Nanomaterials In Personalized Medicine Market In 2026 And What Value Is Projected For 2030?

The market size for nanomaterials in personalized medicine has expanded quickly in recent years. It is anticipated to increase from $392.97 billion in 2025 to $438.79 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be ascribed to progress in genomics and molecular biology, the wider acceptance of targeted therapies, the broadening of translational medical research, the accessibility of advanced nanofabrication techniques, and the growth of academic-industry collaborations.

The nanomaterials in personalized medicine market is set to experience significant expansion in the coming years. It is projected to reach $674.28 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.3%. This growth during the forecast period can be attributed to several factors, including the increasing demand for personalized healthcare solutions, rising investment in precision medicine programs, the expanding use of nanomaterials in diagnostics and imaging, a growing focus on minimizing therapy side effects, and ongoing innovation in nano-enabled medical technologies. Major trends expected during this period include the increasing use of targeted nanomaterials for individualized therapies, the growing integration of molecular diagnostics with nanotechnology, rising adoption of nanomaterials in precision drug delivery, the expansion of nanotechnology into regenerative medicine, and an enhanced focus on patient-specific treatment outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

What Major Drivers Are Influencing Demand In The Nanomaterials In Personalized Medicine Market?

The growing need for personalized medicine is projected to stimulate the expansion of the nanomaterials in personalized medicine market moving forward. Personalized medicine is a medical strategy focused on tailoring treatments for individual patients by considering their genetic, environmental, and lifestyle elements to optimize results and elevate care quality. The rising demand for personalized medicine is attributed to breakthroughs in genomic technologies, which facilitate the accurate identification of genetic variations and the creation of customized treatments for individuals. Nanomaterials are instrumental in personalized medicine, enhancing it by enabling targeted and patient-specific therapies, thereby boosting treatment effectiveness and safety. These materials facilitate the precise delivery of drugs, genes, or RNA, which helps in minimizing side effects and optimizing therapeutic outcomes. For instance, in February 2024, as reported by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, a considerable increase from the 12 approved in 2022. Thus, the escalating demand for personalized medicine is a key factor driving the growth of the nanomaterials in personalized medicine market.

What Are The Key Segments Of The Nanomaterials In Personalized Medicine Market?

The nanomaterials in personalized medicine market covered in this report is segmented –

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

What Key Trends Are Influencing The Development Of The Nanomaterials In Personalized Medicine Market?

Leading firms within the nanomaterials in personalized medicine sector are prioritizing strategic collaborations with the aim of speeding up clinical development, broadening therapeutic uses, and reducing the time required to bring products to market, all while adhering to changing regulatory requirements. These partnerships involve companies or organizations pooling their specialized knowledge and assets to quicken the pace of innovation and broaden prospects within personalized medicine. An illustrative example occurred in May 2025, when Acuitas Therapeutics Inc., a biotechnology firm based in Canada, partnered with Integrated DNA Technologies Inc., a genomics solutions provider from the US. Together, they introduced a method for delivering personalized CRISPR gene-editing therapy, leveraging their lipid nanoparticles platform, which successfully treated one infant suffering from a rare genetic condition. This approach incorporated accurately targeted CRISPR payloads, custom-tailored dose adjustments, and swift bespoke formulation. Such a breakthrough streamlines highly individualized, single-occurrence treatments, thereby enhancing therapeutic accuracy and improving patient results. However, it also introduces complexities concerning large-scale manufacturing, precise regulatory customization, and the production of extremely small volumes.

Who Are The Leading Companies Operating In The Nanomaterials In Personalized Medicine Market?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Read the full nanomaterials in personalized medicine market report here:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Nanomaterials In Personalized Medicine Market?

North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nanomaterials In Personalized Medicine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28276&type=smp

Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company

Nanomaterials In Cosmetic And Personal Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-cosmetic-and-personal-care-global-market-report

Nanomedicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Healthcare Nanotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the nanomaterials in personalized medicine market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Nanomaterials In Personalized Medicine Market?

The market for nanomaterials in personalized medicine has seen rapid expansion in recent years. Its valuation is expected to rise from $392.97 billion in 2025 to $438.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. This past growth can be attributed to developments in genomics and molecular biology, increased adoption of targeted therapies, an expansion of translational medical research, the accessibility of advanced nanofabrication techniques, and a rise in academic-industry collaborations.

The market size for nanomaterials in personalized medicine is projected to experience substantial expansion over the upcoming years. By 2030, this market is forecasted to reach $674.28 billion, driven by a compound annual growth rate (CAGR) of 11.3%. This projected growth during the forecast timeframe is attributable to several factors: a surging demand for tailored healthcare approaches, increased capital flow into precision medicine initiatives, the expanding application of nanomaterials in diagnostic tools and imaging, a heightened emphasis on reducing adverse effects of therapies, and ongoing advancements in medical technologies that utilize nanotechnology. Key trends observed within this forecast period encompass the escalating utilization of targeted nanomaterials for customized treatments, the increasing incorporation of molecular diagnostics with nanotechnology, a growing uptake of nanomaterials for precise drug administration, the broadening scope of nanotechnology in regenerative medicine, and a stronger emphasis on treatment results specific to individual patients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

What Drivers Are Supporting Technological Adoption In The Nanomaterials In Personalized Medicine Market?

The expanding need for individualized healthcare is anticipated to drive the future growth of the nanomaterials in personalized medicine market. Personalized medicine is a medical approach that customizes treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. This increasing demand is fueled by advancements in genomic technologies, which allow for the precise identification of genetic variations and the creation of tailored treatments for individuals. Nanomaterials play a role in enhancing personalized medicine by enabling targeted and patient-specific therapies, which in turn improve treatment efficacy and safety. They facilitate the precise delivery of drugs, genes, or RNA, thereby reducing side effects and optimizing therapeutic outcomes. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, stated that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a considerable increase from the 12 approved in 2022. Thus, the rising demand for personalized medicine is a key driver for the growth of the nanomaterials in personalized medicine market.

What Segment Types Are Examined In The Nanomaterials In Personalized Medicine Market?

The nanomaterials in personalized medicine market covered in this report is segmented –

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

What Trends Are Driving The Growth Trajectory Of The Nanomaterials In Personalized Medicine Market?

Key entities active within the nanomaterials in personalized medicine market are prioritizing strategic collaborations to expedite clinical application, broaden therapeutic uses, and reduce the time to market, all while adhering to evolving regulatory frameworks. These strategic partnerships involve companies or organizations pooling their specialized knowledge and resources to drive innovation and extend possibilities within personalized medicine. As an illustration, in May 2025, Acuitas Therapeutics Inc., a Canada-based biotechnology company, partnered with Integrated DNA Technologies Inc., a US-based genomics solutions provider, to unveil a personalized CRISPR gene-editing therapy delivery mechanism leveraging their lipid nanoparticles platform, which was successfully administered to an infant suffering from a rare genetic disorder. This treatment was characterized by accurately targeted CRISPR components, individualized dose modulation, and swift customized preparation. This advancement expedites highly bespoke, singular treatments. It enhances therapeutic accuracy and patient recovery, yet introduces complexities regarding large-scale production, rigorous regulatory adjustments, and extremely limited volume manufacturing.

Who Are The Top-Performing Companies In The Nanomaterials In Personalized Medicine Market In Recent Years?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

Which Region Currently Holds The Largest Share Of The Nanomaterials In Personalized Medicine Market?

North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nanomaterials In Personalized Medicine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28276&type=smp

Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company

Nanomaterials In Cosmetic And Personal Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-cosmetic-and-personal-care-global-market-report

Nanomedicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Healthcare Nanotechnology Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Nanomaterials In Personalized Medicine Market?

The market size for nanomaterials in personalized medicine has expanded rapidly in recent years. It is projected to grow from $351.41 billion in 2024 to $392.97 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.8%. This historical growth can be attributed to the increasing integration of nanotechnology in drug delivery, a rising demand for targeted therapies, greater awareness regarding the benefits of personalized medicine, an expansion of research into biomarker identification, and the growing prevalence of chronic diseases.

The nanomaterials in personalized medicine market is anticipated to show significant expansion over the next few years, set to reach $606.39 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.5%. This upward trajectory during the forecast period is fueled by factors such as the increasing demand for precision medicine, greater government investment in nanomedicine, a surge in partnerships between biotech and pharma firms, the growing use of advanced diagnostic technologies, and an intensified focus on patient-specific treatment approaches. Prominent developments expected in this period include ongoing technological improvements in nanoparticle design, the emergence of new nano-based drug formulations, innovations in targeted delivery systems, increased spending on research and development for personalized therapies, and the progression of hybrid nanomaterials for medical uses.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

Which Drivers Are Shaping The Nanomaterials In Personalized Medicine Industry’s Market Share?

The rising need for individualized healthcare approaches is anticipated to fuel the expansion of the nanomaterials in personalized medicine market. Personalized medicine refers to a healthcare strategy where treatments are customized for patients considering their unique genetic, environmental, and lifestyle attributes to enhance results and patient care. This surge in demand is attributed to progress in genomic technologies, allowing for accurate detection of genetic differences and the development of specific therapies. Within this context, nanomaterials in personalized medicine improve personalized treatments by facilitating targeted and unique patient therapies, thus boosting effectiveness and safety. They facilitate the accurate delivery of drugs, genes, or RNA, minimizing adverse effects and maximizing therapeutic results. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit, showed that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a notable rise from the 12 approved in 2022. Consequently, the escalating demand for personalized medicine is serving as a key driver for the expansion of the nanomaterials in personalized medicine market.

What Are The Different Segment Classifications Within The Nanomaterials In Personalized Medicine Market?

The nanomaterials in personalized medicine market covered in this report is segmented as

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

Which Trends Are Impacting The Nanomaterials In Personalized Medicine Market?

Leading companies operating within the nanomaterials in personalized medicine market are primarily focused on implementing strategic collaborations to expedite clinical application, broaden therapeutic uses, and reduce the time to market, all while conforming to evolving regulatory benchmarks. Strategic collaborations are defined as partnerships where organizations or institutions pool their expertise and resources to accelerate innovation and expand possibilities in personalized medicine. As an illustration, in May 2025, Acuitas Therapeutics Inc., a biotechnology company based in Canada, partnered with Integrated DNA Technologies Inc., a US-based genomics solutions provider, to introduce a personalized CRISPR gene-editing therapy delivery system. This system, utilizing their lipid nanoparticles platform, successfully treated a single baby with a rare genetic disease, featuring accurately targeted CRISPR payloads, custom dose tuning, and swift custom formulation. This advancement accelerates unique, highly individualized treatments. It significantly improves therapeutic precision and patient outcomes, though it also introduces challenges in scalable manufacturing, stringent regulatory adaptation, and ultra-low-volume production.

Which Major Firms Are Strengthening Their Position In The Nanomaterials In Personalized Medicine Industry?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

How Is Nanomaterials In Personalized Medicine Market Demand Varying Across Different Regions?

North America was the largest region in the nanomaterials in personalized medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nanomaterials in personalized medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Nanomaterials In Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28276&type=smp

Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2025, By The Business Research Company

Nanomaterials In Cosmetic And Personal Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-cosmetic-and-personal-care-global-market-report

Nanomedicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Healthcare Nanotechnology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model